Spironolactone in Diabetic Nephropathy

NCT00317954 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Nephropathy

Interventions

DRUG: Spironolactone

Sponsor

Steno Diabetes Center Copenhagen